Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 67,046 | 71,473 | 48,345 | 61,884 | 99,135 |
| Cost of Goods | 9,088 | 7,699 | 7,036 | 6,710 | 6,937 |
| Gross Profit | 57,958 | 63,774 | 41,309 | 55,174 | 92,198 |
| Operating Expenses | 68,973 | 67,627 | 52,541 | 49,837 | 46,722 |
| Operating Income | -10,927 | -3,154 | -11,196 | 6,047 | 46,413 |
| Other Income | 2,428 | 1,915 | 1,832 | 794 | 322 |
| Pre-tax Income | -8,499 | -1,239 | -9,364 | 6,841 | 46,735 |
| Income Tax | 5,356 | -16,211 | 2,906 | 2,380 | -177,358 |
| Net Income Continuous | -13,855 | 14,972 | -12,270 | 4,461 | 224,093 |
| Net Income | $-13,855 | $14,972 | $-12,270 | $4,461 | $224,093 |
| EPS Basic Total Ops | -0.20 | 0.21 | -0.18 | 0.06 | 3.23 |
| EPS Basic Continuous Ops | -0.20 | 0.21 | -0.18 | 0.07 | 3.23 |
| EPS Diluted Total Ops | -0.20 | 0.21 | -0.18 | 0.07 | 3.18 |
| EPS Diluted Continuous Ops | -0.20 | 0.21 | -0.18 | 0.08 | 3.18 |
| EBITDA(a) | $-10,324 | $-2,552 | $-10,600 | $6,649 | $46,906 |